community-health-executive-summary-english-11.22.pdf
... with a variety of health concerns. As with our previous Community Service Plan, the 2022-2024 Plan focuses ... program, using an evidence-based youth leadership and peer education model. Particular focus ...
Community Events at NYU Langone Hospital—Long Island | NYU Langone Health
NYU Langone Hospital—Long Island provides educational lectures, parent education classes, and support groups for the Long Island community.
Sports Performance Testing & Programs | NYU Langone Health
NYU Langone's Sports Performance Center offers sports performance testing and programs that can help maximize your athletic ability.
Gastrointestinal tract colonization and Staphylococcus aureus associated skin diseases
Our ultimate goal is to improve our understanding of the complex interplay of host, pathogen, and microbiome in Staphylococcus aureus-associated skin diseases. These diseases include both frank infection such as skin and soft tissue infections (SSTIs) and inflammatory diseases with a known high burden of Staphylococcus aureus colonization such as atopic dermatitis. We believe a deeper understanding of the perturbations of S. aureus colonization versus infection and contributions of human host genetics to these perturbations will provide strategies for improved prevention and treatment recommendations.S. aureus gastrointestinal (GI) colonization is an understudied aspect of cutaneous disease and may represent a reservoir for colonization and recurrent infection. The focus of the present proposal will be to determine the role of GI colonization in two syndromes: S. aureus skin abscesses (SSTI; an infection) and atopic dermatitis (AD; a S. aureus-associated skin disease). Furthermore, given that understanding commensal interactions requires consideration of not only environmental but host factors, we will test for an association between GI colonization, microbiota, and host susceptibility gene ATG16L1. ATG16L1 is implicated in inflammatory bowel disease, and our recent work demonstrates that it is associated with S. aureus GI tract colonization in mice. Toward these ends, we will obtain patient data and biobank stool, peripheral blood, and S. aureus from both sets of patients.
Investigation of cellular and molecular interactions in inflammation angiogenesis and immunity in human atherosclerosis: the ATHERO-IN study
Atherosclerotic cardiovascular disease (ACVD) is driven by inflammation and is the leading cause of mortality and disability worldwide, even in optimally treated patients. The impact of many immune cells (inflammatory cells) on atherosclerosis progression is well-established, the contribution of different immune and non-immune cells to human disease pathology and cardiovascular (CV) events remain largely unknown. It is well established that specific histological features of plaque instability are associated with increased risk for cardiovascular events (i.e. stroke, heart attack). This study will address the following knowledge gaps. The ATHERO-IN study is a prospective and retrospective, multisite, observational study. The study will be conducted at two study sites: 1. the NYU Langone Health (coordinating and recruitment site) and 2. the Icahn School of Medicine at Mount Sinai (recruitment site). The Focus of the study is atherosclerotic cardiovascular disease and inflammation. The Goal of the study is to identify new cellular and molecular determinant of atherosclerosis, plaque pathology and cardiovascular events. To achieve this goal, we will use a system biology approach to analyze human samples that will be obtained from patients with atherosclerotic cardiovascular disease from the NYU Langone Health System (NYULH) and from the Mount Sinai Health System (MSHS).
Diagnosing Epilepsy & Seizure Disorders | NYU Langone Health
NYU Langone specialists use exams and imaging tests to diagnose epilepsy and seizure disorders.
Sports Medicine Center | NYU Langone Health
Orthopedic surgeons and sports medicine doctors at NYU Langone’s Sports Medicine Center treat athletic, overuse, and everyday injuries.
chna-csp-final-8-5-19-complete-1.pdf
... Centers at NYU Langone at: kathleen.hopkins@nyulangone.org. ii Table of Contents Section Pages MISSION 1 ... and Plans: Preventing Chronic Diseases 24-49 iii Section Pages A. Tobacco Free Community 24-31 B. Health ...
Child Study Center | NYU Langone Health
The Child Study Center, part of Hassenfeld Children’s Hospital at NYU Langone, treats children with mental health and developmental conditions.
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol: ATRI-001
Discover, optimize, standardize, and validate clinical trial measures and biomarkers used in ongoing AD research.Aim 1. Longitudinal changes in cognition and associated biomarkersDetermine and define those measures of cognition and function, including composite measures, and those biomarker measures, which capture longitudinal change with the highest statistical power to detect treatment effects in clinical trials.Longitudinal change of cerebral tau measured with 18F-AV-1451 PET (AV-1451) will be correlated/compared with other measures.Aim 2. Prediction of cognitive declineDetermine which clinical, cognitive, and biomarker measures that best predict decline of cognition in CN, MCI, and AD participants. In addition, determine which biomarker changes correlate with cognitive decline, with focus on AV-1451 PET.Aim 3. ValidationValidate biomarker measures obtained at Baseline and longitudinally by correlating results with “gold standard” clinical measurements and pathology.Aim 4. Clinical trial designDetermine the optimum outcome measures with attention to cognitive decline and AV-1451 PET, predictors of cognitive decline, and inclusion/exclusion criteria for clinical trials of cognitively normal participants (for secondary preclinical AD trials), MCI patients (for prodromal AD trials) and participants with early dementia due to AD.Aim 5. DiscoveryTo determine the effects of other known disease proteins found in AD brains and genes, as well as newly discovered genes, proteins, and analytes that provide useful information concerning the pathogenesis/diagnosis of AD.Protocol Clarifications:only those with the capacity to consent will be considered for retention in the ADNI study.